AFLD 2012 FFC vs Respondent M83

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M83 for a violation of the Anti-Doping Rules. During a cycling event on March 6, 2012, a sample was taken for doping test purposes. The sample tested positive on the prohibited substance hydrochloriatizide. Hydrochloriatizide is a prohibited substance according the World Anti-Doping Agency prohibited list.

History
The cause of the positive test was medication against high bloodpressure for which the respondent has a medical prescription, also he has as statement of his physician to prove this requirement.

Decision
1. The sanction is a period of ineligibility of one year in which the respondent can't take part in competition or manifestations organized by the FFC or related French sport federations.
2. The present decision shall take effect from the date of notification
sent to the respondent.
3. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
11 October 2012
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Period of ineligibility
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S5. Diuretics and Other Masking Agents
Substances
Hydrochlorothiazide
Medical terms
High Blood Pressure (Hypertension)
Legitimate Medical Treatment
Document type
Pdf file
Date generated
26 February 2014
Date of last modification
11 April 2018
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin